您的当前位置:
首页 >
研究报告 >
公司调研 > 预览报告
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=4455653","PageTitle":"银杏二萜内酯葡胺注射液医保谈判及医保调整品种分析-公司调研 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":97,"Face":"/_files/face/0/t0p3qgmu.jpg","UName":"戚雅容","UpArts":0,"UpRpts":23099,"UpLbies":33},"Rid":4455653,"IsPdf":true,"IsExist":true,"PdfUrl":"/download2.mtachn.com/upload/report/公司调研/20170307-华创证券-康缘药业-600557.SH-银杏二萜内酯葡胺注射液医保谈判及医保调整品种分析.pdf","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}